Biozone Pharmaceuticals, Inc. BZNE Company Overview 

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Biozone Pharmaceuticals, Inc. BZNE Company Overview 

Stock Message Board http://investorshangout.com/search?q=BZNE&...mp;yt1=Go!

Biozone Pharmaceuticals, Inc. BZNE Current Price and Quotes
Last Price 0.69
Previous Close 0.65 Open 0.61
Daily Range 0.69 - 0.61 52wk Range 3.75 - 0.16
Volume 2,864 Dividend N/A
Average Vol (3m) 3,955 Yield N/A
Biozone Pharmaceuticals, Inc. BZNE
Company Information

550 Sylvan Avenue
Suite 101
Englewood Cliffs, NJ 07632

Phone: 201-608-5101

Biozone Pharmaceuticals, Inc. BZNE
Biozone Pharmaceuticals, Inc. BZNE
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2013 10-Q
CIK 0001412486
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o Dec 31, 0007
Incorporated In: NV, USA
Year of Inc. 2006
Employees Not Available
Company Officers/Contacts

Elliot Maza Interim CEO, CFO
Roberto Prego Novo President, Principal Acct. Officer
Company Directors

Roberto Prego Novo
Company Notes

Formerly=International Surf Resorts, Inc. until 3-2011
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
M2 Law Professional Corp.
500 Newport Center Dr.
Newport Beach, CA, 92660
United States

Investor Relations Firm
Not Available

Biozone Pharmaceuticals, Inc. BZNE
BZNE Security Details

Share Structure

Market Value1 $45,247,361 a/o Sep 13, 2013
Shares Outstanding 69,611,325 a/o Jul 31, 2013
Float Not Available
Authorized Shares Not Available
Par Value  0.001
Shareholders

Shareholders of Record 257 a/o Apr 01, 2013
Corporate Actions

Ex. Date Record Date Pay Date
Dividend (0.00) Mar 15, 2011 Mar 11, 2011 Mar 14, 2011
Security Notes

Capital Change=shs increased by 10 for 1 split. Ex-date=03/15/2011. Rec date=03/11/2011. Pay date=03/14/2011.
Short Selling Data

Short Interest 1,126 (0%)
Aug 30, 2013
Significant Failures to Deliver  No
Transfer Agent(s)



Biozone Pharmaceuticals, Inc. BZNE Recent News

Biozone Pharmaceuticals, Inc. BZNE Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 17,191 12,605 15,254 -
Cost of Revenue 9,969 9,920 8,428 -
Gross Profit 7,222 2,686 6,826 -
Operating Expenses

Research and Development 743 423 241 -
Sales, General and Admin. 9,115 6,149 6,617 9
Non-Recurring Items - - - 34
Other - - - -
Operating Income (2,637) (3,887) (32) (43)
Income From Continuing Operations

Add'l Income/Expense Items 154 (282) - -
Earnings Before Interest and Tax (2,483) (4,211) 23 (43)
Interest Expense 5,482 1,243 439 -
Earnings Before Tax (7,965) (5,454) (416) (43)
Income Tax - 3 (96) -
Minority Interest - - - (1)
Equity Earnings Unconsolidated Subsidiary - (43) 55 -
Net Income Cont. Operations (7,965) (5,500) (265) (41)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (7,965) (5,457) (320) (41)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (7,965) (5,457) (320) (41)

BZNE Biozone Pharmaceuticals, Inc. Research DD Guide

BZNE Biozone Pharmaceuticals, Inc. Stock Message Board http://investorshangout.com/search?q=BZNE&...mp;yt0=Go!
BZNE Biozone Pharmaceuticals, Inc. Stock Quote http://www.otcmarkets.com/stock/BZNE/quote
BZNE Biozone Pharmaceuticals, Inc. Stock Chart http://www.otcmarkets.com/stock/BZNE/chart
BZNE Biozone Pharmaceuticals, Inc. Company Info http://www.otcmarkets.com/stock/BZNE/company-info
BZNE Biozone Pharmaceuticals, Inc. Recent News http://www.otcmarkets.com/stock/BZNE/news
BZNE Biozone Pharmaceuticals, Inc. Financials http://www.otcmarkets.com/stock/BZNE/financials
BZNE Biozone Pharmaceuticals, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/BZNE/filings
BZNE Biozone Pharmaceuticals, Inc. Short Sales http://www.otcmarkets.com/stock/BZNE/short-sales
BZNE Biozone Pharmaceuticals, Inc. Insider Disclosure http://www.otcmarkets.com/stock/BZNE/insider-transactions
BZNE Biozone Pharmaceuticals, Inc. Research Reports http://www.otcmarkets.com/stock/BZNE/research
BZNE Biozone Pharmaceuticals, Inc. Summary http://finance.yahoo.com/q?s=BZNE
BZNE Biozone Pharmaceuticals, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=BZNE+Historical+Prices
BZNE Biozone Pharmaceuticals, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=BZNE
BZNE Biozone Pharmaceuticals, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=BZNE+Basic+Chart
BZNE Biozone Pharmaceuticals, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=BZNE+Basic+Tech.+Analysis
BZNE Biozone Pharmaceuticals, Inc. Headlines http://finance.yahoo.com/q/h?s=BZNE+Headlines
BZNE Biozone Pharmaceuticals, Inc. Press Releases http://finance.yahoo.com/q/p?s=BZNE+Press+Releases
BZNE Biozone Pharmaceuticals, Inc. Company Profile http://finance.yahoo.com/q/pr?s=BZNE+Profile
BZNE Biozone Pharmaceuticals, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=BZNE+Key+Statistics
BZNE Biozone Pharmaceuticals, Inc. Industry http://finance.yahoo.com/q/in?s=BZNE+Industry
BZNE Biozone Pharmaceuticals, Inc. Major Holders http://finance.yahoo.com/q/mh?s=BZNE+Major+Holders
BZNE Biozone Pharmaceuticals, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=BZNE+Insider+Transactions
BZNE Biozone Pharmaceuticals, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=BZNE+Insider+Roster
BZNE Biozone Pharmaceuticals, Inc. Income Statement http://finance.yahoo.com/q/is?s=BZNE
BZNE Biozone Pharmaceuticals, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=BZNE
BZNE Biozone Pharmaceuticals, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=BZNE+Cash+Flow&annual
BZNE Biozone Pharmaceuticals, Inc. Nasdaq http://www.nasdaq.com/symbol/BZNE
BZNE Biozone Pharmaceuticals, Inc. Market Watch http://www.marketwatch.com/investing/stock/BZNE
BZNE Biozone Pharmaceuticals, Inc. Bloomberg http://www.bloomberg.com/quote/BZNE:US
BZNE Biozone Pharmaceuticals, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=BZNE
BZNE Biozone Pharmaceuticals, Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=BZNE
BZNE Biozone Pharmaceuticals, Inc. Barchart http://www.barchart.com/quotes/stocks/BZNE
BZNE Biozone Pharmaceuticals, Inc. OTC Short Report http://otcshortreport.com/index.php?index=BZNE
BZNE Biozone Pharmaceuticals, Inc. Investopedia http://www.investopedia.com/markets/stocks/BZNE/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 372

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading
MV Transportation Celebrates Leadership Nomination for FTA

Updated Category News Views 174

MV Throws Support Behind Aesch for FTA Role In this wild world where public transit feels the heat from financial burdens, MV Transportation's recent move to support Mark Aesch for the Federal Transit Administration's top spot isn’t just a nod of approval—it's a full-blown trumpet blast. They're not just doling out a basic endorsement here; they're practically waving...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 200

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 186

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 268

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 203

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 257

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 253

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 170

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading

Top 5 Most Recently Viewed Articles

FedEx's Exchange Offer Extension: What Investors Need to Know

Updated Category News Views 235

FedEx Extends Expiration Date for Exchange Offers In an important update for investors, FedEx Corp. (NYSE: FDX) has announced the extension of the expiration date for its ongoing offers to exchange certain senior notes. These adjustments may significantly impact eligible holders as they look to navigate the investment landscape. The new expiration date is scheduled for...

Continue Reading
Orbit International Secures $1.5M in New Power Contracts

Updated Category News Views 234

Orbit International's Recent Achievements Orbit International Corp. (OTCID Basic Market:ORBT), headquartered in Hauppauge, N.Y., is making waves in the electronics manufacturing industry. Recently, its Power Group (OPG) has achieved significant contract awards totaling approximately $1,500,000. This robust activity highlights Orbit International's commitment to delivering...

Continue Reading
Investors in James Hardie Industries Face Class Action Updates

Updated Category News Views 264

Understanding the Class Action Lawsuit Against James Hardie Industries James Hardie Industries plc, a well-known manufacturer of fiber cement products, is currently facing significant scrutiny due to a class action lawsuit. This action concerns investors who purchased shares of the company's common stock, specifically during a period that many believe was marked by...

Continue Reading
Empowering Women through Construction: 84 Lumber's Special Tribute

Updated Category News Views 434

Empowering Women through Construction In honoring Women in Construction (WIC) Week, 84 Lumber proudly shines a spotlight on the remarkable contributions made by women in the construction industry. As a leading name in the building materials sector, 84 Lumber emphasizes its commitment to empowering women and creating an environment where they can thrive. During this...

Continue Reading
Dune Acquisition Corporation II Successfully Completes IPO Today

Updated Category News Views 273

Dune Acquisition Corporation II Completes Successful IPO Dune Acquisition Corporation II has recently announced the successful closing of its initial public offering (IPO), an important milestone for the company and its stakeholders. The IPO was priced at $10.00 per unit, and the total gross proceeds from this offering reached an impressive $143,750,000. A total of...

Continue Reading